Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | NVCR | ZYME | ||
| Company | Recursion Pharmaceuticals Inc Cl A | Novocure Ltd Ord Sh | Zymeworks Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.80 | 17.20 | 27.03 | ||
| High | 3.80 | 17.35 | 27.13 | ||
| Low | 3.44 | 16.01 | 25.36 | ||
| Latest | 3.56 | 16.30 | 25.84 | ||
| Change | -0.20 | -0.99 | -1.23 | ||
| % Change | -5.32% | -5.73% | -4.54% | ||
| Volume | 18,752,834 | 713,673 | 365,802 | ||
| 20-Day Average Volume | 23,034,365 | 1,789,161 | 694,016 | ||
| Previous Close | 3.76 | 17.29 | 27.07 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.46 | 16.27 | 24.55 | ||
| 20-Day Raw Stochastic | 53.07% | 61.79% | 70.36% | ||
| 20-Day Relative Strength | 52.22 | 51.27 | 53.67 | ||
| Weighted Alpha | -30.58 | -1.64 | +66.04 | ||
| Today's Opinion | 8% Sell | 56% Buy | 40% Buy | ||
| Previous Opinion | 8% Buy | 72% Buy | 56% Buy | ||
| Last Month's Opinion | 88% Sell | 88% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.45% since 07/02/26 | -4.24% since 07/02/26 | -2.01% since 07/02/26 | ||
| Low | 3.44 on 07/10/26 | 16.01 on 07/10/26 | 24.70 on 07/06/26 | ||
| High | 4.09 on 07/06/26 | 18.08 on 07/08/26 | 27.41 on 07/09/26 | ||
| 1-Month | |||||
| %Chg | +16.94% since 06/10/26 | -1.08% since 06/10/26 | +12.82% since 06/10/26 | ||
| Low | 2.95 on 06/11/26 | 13.43 on 06/23/26 | 21.91 on 06/29/26 | ||
| High | 4.09 on 07/06/26 | 18.35 on 06/15/26 | 27.41 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +8.38% since 04/10/26 | +55.67% since 04/10/26 | -2.05% since 04/10/26 | ||
| Low | 2.77 on 05/19/26 | 10.40 on 04/13/26 | 21.91 on 06/29/26 | ||
| High | 4.09 on 07/06/26 | 18.92 on 05/11/26 | 29.75 on 04/27/26 | ||
| 6-Month | |||||
| %Chg | -23.71% since 01/09/26 | +14.77% since 01/09/26 | +11.26% since 01/09/26 | ||
| Low | 2.77 on 05/19/26 | 9.82 on 02/09/26 | 21.91 on 06/29/26 | ||
| High | 5.24 on 01/22/26 | 18.92 on 05/11/26 | 29.75 on 04/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,992,443 | 2,002,545 | 1,976,733 | ||
| Shares Outstanding, K | 529,905 | 115,821 | 73,023 | ||
| Annual Sales | 74,680,000 | 655,350,000 | 105,970,000 | ||
| Annual Net Income | -644,760,000 | -136,230,000 | -81,130,000 | ||
| Last Quarter Sales | 6,470,000 | 174,060,000 | 2,410,000 | ||
| Last Quarter Net Income | -117,500,000 | -71,140,000 | -44,160,000 | ||
| 60-Month Beta | 1.00 | 0.94 | 1.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 05/06/26 | -0.62 on 04/30/26 | -0.59 on 05/07/26 | ||
| Earnings Date | 08/04/26 | 07/23/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||